Sign In
Buy AKRO
$54.65
+0 (+0%)
At Close: Mar 06, 2026
Intercept Pharmaceuticals receives FDA Complete Response Letter for treatment for fibrosis due to NASH
11:24am, Monday, 29'th Jun 2020
Intercept Pharmaceuticals Inc. shares undefined tumbled more than 30% in premarket trade Monday, after the company said it has received a U.S. Food and Drug...
Legend Biotech (NASDAQ:PLRX) Reaches New 12-Month High at $32.79
11:10am, Monday, 29'th Jun 2020
Shares of Legend Biotech Corporation (NASDAQ:PLRX) hit a new 52-week high on Monday . The company traded as high as $32.79 and last traded at $32.75, with a volume of 445 shares trading hands. The sto
Cowen Initiates Coverage on Legend Biotech (NASDAQ:PLRX)
08:26am, Monday, 29'th Jun 2020
Stock analysts at Cowen began coverage on shares of Legend Biotech (NASDAQ:PLRX) in a research report issued to clients and investors on Monday, BenzingaRatingsTable reports. The brokerage set an “o
Integrating Echosens’ FibroScan into MetaPhy’s Chronic Care Liver Disease Management Program Impacts Patient Outcomes, Costs, Financial Performance
Financial Comparison: GENFIT S A/ADR (GNFT) versus The Competition
02:20am, Sunday, 28'th Jun 2020
GENFIT S A/ADR (NASDAQ: GNFT) is one of 141 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare GENFIT S A/AD
Is Akero Therapeutics, Inc. (AKRO) A Good Stock To Buy?
01:28am, Sunday, 28'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Akero Therapeutics (NASDAQ:AKRO) Shares Purchased by Victory Capital Management Inc.
07:18am, Saturday, 27'th Jun 2020
Victory Capital Management Inc. lifted its position in Akero Therapeutics (NASDAQ:AKRO) by 2,010.9% during the 1st quarter, according to the company in its most recent filing with the Securities and E
GENFIT S A/ADR (GNFT) versus Its Rivals Head to Head Contrast
01:16am, Friday, 26'th Jun 2020
GENFIT S A/ADR (NASDAQ: GNFT) is one of 141 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its rivals? We will compare GENFIT S A/AD
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
12:00am, Friday, 26'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 25)
Brainstorm Cell...
Poxel : annonce les résultats de son Assemblée générale ordinaire annuelle et extraordinaire du 24 juin 2020 | Zone bourse
03:02pm, Thursday, 25'th Jun 2020What Algernon is doing to potentially combat COVID-19
01:00pm, Thursday, 25'th Jun 2020
Algernon Pharmaceuticals Inc. (CSE: AGN | OTCQB: AGNPF | FSE: AGW) is a clinical stage drug development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney di…
Akero Therapeutics (NASDAQ:AKRO) Lifted to “Buy” at Zacks Investment Research
02:52am, Thursday, 25'th Jun 2020
Zacks Investment Research upgraded shares of Akero Therapeutics (NASDAQ:AKRO) from a hold rating to a buy rating in a research note released on Monday morning, Zacks.com reports. Zacks Investment Rese
Poxel annonce les résultats de son Assemblée générale ordinaire annuelle et extraordinaire du 24 juin 2020
12:00am, Thursday, 25'th Jun 2020
Regulatory News : POXEL SA (Paris:POXEL) (Euronext : POXEL - FR0012432516), société biopharmaceutique spécialisée dans le développement de traitements
Combination Pill From Myovant Reduces Pain From Endometriosis, Trial Shows
01:32pm, Wednesday, 24'th Jun 2020
Read about the biggest pharmaceutical development and pricing stories from the past week in KHN’s Prescription Drug Watch roundup.
Advocates Want More Warnings From FDA On Diabetes Drug Linked To Fatal Reactions
01:32pm, Wednesday, 24'th Jun 2020
Because the drug can cause a potentially fatal condition called ketoacidosis in diabetic patients, advocates are calling on the FDA to issue a “black box” warning–the most severe …
